Early onset of homozygous betao-thalassaemia associated with neonatal jaundice. 1978

M Furbetta, and P Cossu, and A Angius, and G Congiu, and A Ximenes, and A Cao

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D007567 Jaundice, Neonatal Yellow discoloration of the SKIN; MUCOUS MEMBRANE; and SCLERA in the NEWBORN. It is a sign of NEONATAL HYPERBILIRUBINEMIA. Most cases are transient self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) occurring in the first week of life, but some can be a sign of pathological disorders, particularly LIVER DISEASES. Icterus Gravis Neonatorum,Neonatal Jaundice,Physiological Neonatal Jaundice,Severe Jaundice in Neonate,Severe Jaundice in Newborn,Jaundice, Physiological Neonatal,Neonatal Jaundice, Physiological
D005078 Exchange Transfusion, Whole Blood Repetitive withdrawal of small amounts of blood and replacement with donor blood until a large proportion of the blood volume has been exchanged. Used in treatment of fetal erythroblastosis, hepatic coma, sickle cell anemia, disseminated intravascular coagulation, septicemia, burns, thrombotic thrombopenic purpura, and fulminant malaria.
D005260 Female Females
D005914 Globins A superfamily of proteins containing the globin fold which is composed of 6-8 alpha helices arranged in a characterstic HEME enclosing structure. Globin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias

Related Publications

M Furbetta, and P Cossu, and A Angius, and G Congiu, and A Ximenes, and A Cao
January 1979, Archives of disease in childhood,
M Furbetta, and P Cossu, and A Angius, and G Congiu, and A Ximenes, and A Cao
March 1977, Nature,
M Furbetta, and P Cossu, and A Angius, and G Congiu, and A Ximenes, and A Cao
September 1977, Nature,
M Furbetta, and P Cossu, and A Angius, and G Congiu, and A Ximenes, and A Cao
November 1995, JPMA. The Journal of the Pakistan Medical Association,
M Furbetta, and P Cossu, and A Angius, and G Congiu, and A Ximenes, and A Cao
July 1977, Proceedings of the National Academy of Sciences of the United States of America,
M Furbetta, and P Cossu, and A Angius, and G Congiu, and A Ximenes, and A Cao
July 1978, British journal of haematology,
M Furbetta, and P Cossu, and A Angius, and G Congiu, and A Ximenes, and A Cao
January 1994, Folia medica,
M Furbetta, and P Cossu, and A Angius, and G Congiu, and A Ximenes, and A Cao
January 2011, International journal of pediatric endocrinology,
M Furbetta, and P Cossu, and A Angius, and G Congiu, and A Ximenes, and A Cao
February 1972, American journal of diseases of children (1960),
M Furbetta, and P Cossu, and A Angius, and G Congiu, and A Ximenes, and A Cao
February 1961, The Journal of the Arkansas Medical Society,
Copied contents to your clipboard!